Expertise in
87
conditions

Dr. Bassam I. Mattar

Hematology | Oncology
818 N Emporia St, Ste 403, 
Wichita, KS 
Accepting New Patients
Expertise in
87
conditions
818 N Emporia St, Ste 403, 
Wichita, KS 

Overview

Bassam I. Mattar, MD, is an experienced, board-certified hematologist at Ascension Via Christi in Wichita, Kansas. Dr. Mattar diagnoses and treats blood diseases and blood cancer. Every appointment with Dr. Mattar starts with a conversation. He takes the time to answer all your questions - big and small.

Dr. Mattar is highly rated in 87 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Richter Syndrome, Lynch Syndrome, Colorectal Cancer, and Bone Marrow Transplant.

Dr. Mattar is board certified in The American Board Of Internal Medicine - Hematology, The American Board Of Internal Medicine - Medical Oncology, and The American Board Of Internal Medicine - Internal Medicine. He is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 2 clinical trials. Dr. Mattar is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in KS

Board Certifications

The American Board Of Internal Medicine - Hematology
The American Board Of Internal Medicine - Medical Oncology
The American Board Of Internal Medicine - Internal Medicine

Fellowships

University of Alabama - Birmingham
University of Alabama Hospital

Hospital Affiliations

Kingman Healthcare Center
Ascension Via Christi Hospitals Wichita, Inc.
Hillsboro Community Hospital
St Luke Hospital & Living Center
Nmc Health
Ascension Via Christi St. Francis
Ascension Via Christi St. Joseph
Ascension Via Christi St. Teresa

Languages Spoken

English
Arabic
French
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Medica
  • EPO
  • HMO
  • PPO
MVP Health
  • EPO
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
US Health and Life
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Cancer Center of Kansas
818 N Emporia St, Ste 403, Wichita, KS 67214

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting
Enrollment Status: Completed
Publish Date: February 27, 2025
Intervention Type: Biological
Study Drug: lisocabtagene maraleucel
Study Phase: Phase 2

15 Total Publications

OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.
OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.
Journal: Blood advances
Published: March 25, 2024
Similar Doctors
Expertise in
73
conditions
Dr. Shaker R. Dakhil
Hematology | Oncology
Expertise in
73
conditions
Dr. Shaker R. Dakhil
Hematology | Oncology
Referral may be required

Cancer Center Of Kansas

818 N Emporia St, Ste 403, 
Wichita, KS 
 (0.1 miles away)
316-262-4467
Languages Spoken:
English, Arabic, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Shaker R. Dakhil, MD, is an experienced, board-certified hematologist at Ascension Via Christi in Wichita, Kansas. Dr. Dakhil diagnoses and treats blood diseases and blood cancer. Every appointment with Dr. Dakhil starts with a conversation. He takes the time to answer all your questions - big and small. Dr. Dakhil is highly rated in 73 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Breast Cancer, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Dakhil is board certified in The American Board Of Internal Medicine - Medical Oncology and The American Board Of Internal Medicine - Internal Medicine. Dr. Dakhil is currently accepting new patients.

Expertise in
38
conditions
Dr. Christopher S. Dakhil
Hematology | Oncology
Expertise in
38
conditions
Dr. Christopher S. Dakhil
Hematology | Oncology
Referral may be required

Cancer Center Of Kansas

818 N Emporia St, Ste 403, 
Wichita, KS 
 (0.1 miles away)
316-262-4467
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Dakhil is a Hematologist and an Oncologist practicing medicine in Wichita, Kansas. Dr. Dakhil is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Familial Colorectal Cancer. Dr. Dakhil is board certified in The American Board Of Internal Medicine - Hematology and The American Board Of Internal Medicine - Medical Oncology. Dr. Dakhil is currently accepting new patients.

Expertise in
51
conditions
Dr. Jeremy M. Deutsch
Hematology | Oncology
Expertise in
51
conditions
Dr. Jeremy M. Deutsch
Hematology | Oncology
Referral may be required

Cancer Center Of Kansas

818 N Emporia St, Ste 403, 
Wichita, KS 
 (0.1 miles away)
316-262-4467
Languages Spoken:
English, American Sign Language, Arabic, French, Japanese, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeremy Deutsch is a Hematologist and an Oncologist practicing medicine in Wichita, Kansas. Dr. Deutsch is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Familial Colorectal Cancer. Dr. Deutsch is board certified in The American Board Of Internal Medicine - Hematology and The American Board Of Internal Medicine - Medical Oncology. Dr. Deutsch is currently accepting new patients.

Frequently Asked Questions about Dr. Bassam I. Mattar

How do I make an appointment with Dr. Bassam I. Mattar?

You can book an appointment with Dr. Bassam I. Mattar by calling their office at 316-262-4467. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Bassam I. Mattar a top-rated expert for Myelodysplastic Syndrome (MDS)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bassam I. Mattar is classified as an Distinguished expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Bassam I. Mattar specialize in?

While Dr. Bassam I. Mattar is a Hematology, they have specific expertise in Myelodysplastic Syndrome (MDS), Richter Syndrome, and Lynch Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Bassam I. Mattar participate in research or clinical trials?

Yes. Dr. Bassam I. Mattar has published 15 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Dr. Bassam I. Mattar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Bassam I. Mattar accept my insurance?

Dr. Bassam I. Mattar accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 316-262-4467 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mattar's expertise for a condition
ConditionClose
    View All 23 Distinguished Conditions
    View All 64 Advanced Conditions
    View All 91 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile